Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026)

Pro Dex's (PDEX) quarterly Net Income towards Common Stockholders came in at $3.9 million in Q1 2026, up 20.24% year-on-year from $3.3 million in Q1 2025, and up 80.06% quarter-over-quarter from $2.2 million in Q4 2025.

Pro Dex (PDEX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Pro Dex has disclosed Net Income towards Common Stockholders across 14 years of filings, most recently posting $3.9 million for Q1 2026.

  • Net Income towards Common Stockholders for Q1 2026 came in at $3.9 million, up 20.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 28.12% YoY), and the FY2025 annual result was $9.0 million, up 322.1% from the prior year.
  • Net Income towards Common Stockholders came in at $3.9 million for Q1 2026 at Pro Dex, up from $2.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $4.7 million in Q3 2025 to a low of -$615000.0 in Q3 2023.
  • The 5-year median for Net Income towards Common Stockholders is $1.6 million (2023), against an average of $1.9 million.
  • Across the five-year window, Net Income towards Common Stockholders slumped 151.12% in 2023 and surged 500.98% in 2024, its largest moves.
  • Pro Dex's Net Income towards Common Stockholders stood at $2.8 million in 2022, then tumbled by 81.83% to $500000.0 in 2023, then surged by 308.0% to $2.0 million in 2024, then grew by 7.21% to $2.2 million in 2025, then jumped by 80.06% to $3.9 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $3.9 million (Q1 2026), $2.2 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 826.00 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -274.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 239.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 398.73 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 135.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 13.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -77.90 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 112.77 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 2.00 Mn
10 Pro Dex 200.16 Mn 192.54 Mn 6.13 Mn 3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.94 Mn
Dec 31, 2025 2.19 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 3.28 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 2.47 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 655,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 -615,000.00
Jun 30, 2023 1.50 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 2.75 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 2.12 Mn
Mar 31, 2022 462,000.00
Dec 31, 2021 925,000.00
Sep 30, 2021 1.37 Mn
Jun 30, 2021 1.10 Mn